Clinical trial
Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan…
NCT00083564 · Poniard Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00083564 |
|---|---|
| Title | Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma |
| Official title | A Randomized Multicenter Study to Compare the Safety and Efficacy of 166Ho-DOTMP Plus Melphalan to Melphalan Alone as Conditioning for Autologous Peripheral Blood Stem Cell Transplant in Subjects With Primary Refractory Multiple Myeloma |
| Lead sponsor | Poniard Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | STR(TM) (Skeletal Targeted Radiotherapy, Holmium-166-DOTMP) |
| Enrollment | 240 |
| Start date | Mar 1, 2004 |
| First posted | May 28, 2004 |
| Last update posted | Mar 31, 2009 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: